Mukka Proteins Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
- October 9, 2026
- Posted by: Ankit Jaiswal
- Category: Market
CMP Rs 26.49 (9 Oct 2026). 52W range Rs 18.27 to Rs 33.29. PE 10.76. 2027 base Rs 29.7, bull Rs 34.2.
Quick Answer
The Mukka Proteins share price forecast for 2027 centres on a conservative case of Rs 29.7, a base case of Rs 29.7 and a bull case of Rs 34.2, against a current price of Rs 26.49. These targets scale today’s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 12.1% upside from today’s price. The daily technical setup reads mildly bearish.
Mukka Proteins share price prediction 2027 comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 26.49 on NSE as of 9 October 2026, 20.4% below its 52-week high of Rs 33.29, after the company reported net profit of Rs 57.09 crore for FY26.
This Mukka Proteins stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.
Click Here – Get Free Investment Predictions
Mukka Proteins Share Price Today and Key Data
The Mukka Proteins share price today is Rs 26.49 on NSE, up 0.38% on the day. The market capitalisation stands at Rs 797 crore. Over the past year the price has risen 0.4% from Rs 26.39. Every Mukka Proteins stock forecast figure below starts from this price.
| Metric | Value |
|---|---|
| Company | Mukka Proteins (MUKKA) |
| Current Price | Rs 26.49 |
| 52-Week High | Rs 33.29 (15 September 2026) |
| 52-Week Low | Rs 18.27 (30 March 2026) |
| Market Cap | Rs 797 crore |
| PE Ratio | 10.76 |
| Industry PE | 34.85 |
| PB Ratio | 1.60 |
| EPS (TTM) | Rs 2.47 |
| Return on Equity | 10.43% |
| Debt to Equity | 1.56 |
| Dividend Yield | 0.00% |
| Book Value per Share | Rs 16.64 |
What Is the Mukka Proteins Share Price Prediction for 2027?
The Mukka Proteins share price prediction for 2027 is a conservative case of Rs 29.7, a base case of Rs 29.7 and a bull case of Rs 34.2. Against Rs 26.49, these imply 12.1% upside, 12.1% upside and 29.1% upside. They are model scenarios built from reported EPS growth, not broker targets.
| Scenario | EPS Growth Basis | EPS Estimate | PE Multiple | Implied Value | Upside vs Current Price |
|---|---|---|---|---|---|
| Conservative Case | Lower of FY26 growth (12.3%) and 4-year CAGR (12.1%) | Rs 2.77 (+12.1%) | Unchanged from today (price to EPS ratio kept constant) | Rs 29.7 | +12.1% |
| Base Case | Average of the two | Rs 2.77 (+12.2%) | Unchanged from today (price to EPS ratio kept constant) | Rs 29.7 | +12.1% |
| Bull Case | Higher of the two | Rs 2.77 (+12.3%) | Re-rated 15.0% toward industry PE of 34.85 (still at or below it) | Rs 34.2 | +29.1% |
Each target takes today’s price of Rs 26.49 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. The bull case also re-rates the PE multiple toward the industry level, because the stock trades below it. Together they form the Mukka Proteins target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.
Mukka Proteins Share Price Forecast: What Has to Go Right by 2027
Each Mukka Proteins target price below depends on a specific EPS outcome, and the text states that outcome next to the number.
Conservative Case for the Mukka Proteins Share Price Target: Rs 29.7
Reaching Rs 29.7 needs EPS to rise 12.1% to Rs 2.77 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 12.1%.
Base Case for the Mukka Proteins Share Price Target: Rs 29.7
Reaching Rs 29.7 needs EPS to rise 12.2% to Rs 2.77, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of 1071.7% in Q1 FY27 is at or above that pace, which supports the target.
Bull Case for the Mukka Proteins Share Price Target: Rs 34.2
Reaching Rs 34.2 needs EPS to rise 12.3% to Rs 2.77 and the PE multiple to re-rate 15.0% toward the industry PE. That is above the 52-week high of Rs 33.29, so it would need a fresh breakout. A daily close above the nearest resistance level of Rs 26.65 (50-day SMA) would be the first technical confirmation.
Mukka Proteins Financial Performance: Revenue, Profit and Margins
Mukka Proteins earned net profit of Rs 57.09 crore on revenue of Rs 1,478.13 crore in FY26, with profit up 18.7% and revenue up 44.7% compared with FY25. Diluted EPS was Rs 1.74 against Rs 1.55 a year earlier, and that earnings base anchors the Mukka Proteins share price forecast.
| Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Operating Margin | Net Margin |
|---|---|---|---|---|---|
| FY22 | 777.96 | 25.82 | 1.10 | 7.04% | 3.32% |
| FY23 | 1,183.80 | 47.52 | 2.00 | 8.01% | 4.01% |
| FY24 | 1,396.14 | 74.31 | 3.10 | 9.05% | 5.32% |
| FY25 | 1,021.53 | 48.10 | 1.55 | 11.04% | 4.71% |
| FY26 | 1,478.13 | 57.09 | 1.74 | 10.03% | 3.86% |
In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 491.24 crore against Rs 173.33 crore a year earlier (+183.4%), and the bottom line was a net profit of Rs 18.63 crore against a net profit of Rs 1.59 crore (+1071.7%). Operating margin was 10.24% versus 10.10% in the year-ago quarter. Cash flow from operations was Rs -111.27 crore in FY26 against Rs -111.93 crore in FY25. Together these figures set the earnings base for the Mukka Proteins share price prediction.
Check the Univest Screener for live Mukka Proteins fundamentals
Is Mukka Proteins Overvalued or Undervalued Right Now?
Mukka Proteins trades at a PE of 10.76 against an industry PE of 34.85, which places the stock at a 69.1% discount to the industry average. The price-to-book ratio is 1.60 on a book value of Rs 16.64 per share. Return on equity of 10.43% means the company earns Rs 10.43 of profit for every Rs 100 of shareholder equity.
Debt to equity is 1.56, so borrowings equal about 156% of shareholder equity. No dividend was declared for FY26. This valuation context frames the Mukka Proteins stock price prediction for 2027 without relying on any outside forecast.
Mukka Proteins Stock Analysis: Technical Outlook
Mukka Proteins stock trades below its 50-day SMA of Rs 26.65 and above its 200-day EMA of Rs 25.41, and the combined daily indicators read mildly bearish. The 52-week high of Rs 33.29 was set on 15 September 2026, while the 52-week low of Rs 18.27 came on 30 March 2026.
| Indicator | Reading | Signal |
|---|---|---|
| RSI (14) | 45.67 | Neutral |
| MACD (12,26,9) | -0.27 vs signal -0.05 | Bearish |
| ADX (14) | 39.32 | Established trend |
| Supertrend (10,3) | Price below Rs 29.48 | Bearish |
| 50-day SMA | Rs 26.65 | Price below |
| 200-day EMA | Rs 25.41 | Price above |
The nearest support level sits at Rs 25.41 (200-day EMA) and Rs 18.27 (52-week low). The nearest resistance level sits at Rs 26.65 (50-day SMA) and Rs 29.48 (Supertrend). A sustained move above the nearest resistance would support the Mukka Proteins share price prediction 2027 base case, and this Mukka Proteins stock analysis uses daily candles only.
Mukka Proteins Shareholding Pattern
Promoters hold 73.33% of Mukka Proteins as of Jun 2026, unchanged across the last 5 quarters. FII holding is 1.73% (down from 2.08% in Jun 2025) and DII holding is 0.00% (down from 1.87% in Jun 2025), which puts combined institutional holding at 1.73%. Public shareholders own 24.93%. Shareholding data is one input for any Mukka Proteins stock forecast.
Key Risks to the Mukka Proteins Share Price Target for 2027
Earnings and Margin Risk
Operating margin has ranged from 7.04% to 11.04% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Mukka Proteins stock forecast. Revenue was up 44.7% in FY26, and slower revenue growth would weigh on the profit path.
Size and Liquidity Risk
Market capitalisation stands at Rs 797 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Mukka Proteins stock price target.
Balance Sheet Risk
Debt to equity of 1.56 means borrowings stand at about 156% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Mukka Proteins share price forecast.
Technical Risk
The daily indicators read mildly bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 25.41 (200-day EMA) would weaken the setup further.
Conclusion
This Mukka Proteins stock analysis puts the share price target range for 2027 at Rs 29.7 to Rs 34.2, with a base case of Rs 29.7 against Rs 26.49 today. The inputs are a PE of 10.76 that sits at a 69.1% discount to the industry average, EPS growth of 12.3% in FY26 and a daily technical setup that reads mildly bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.
Download the Univest iOS App or Univest Android App to track Mukka Proteins live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Mukka Proteins Share Price Prediction 2027
What is the Mukka Proteins share price target for 2027?
Ans. The Mukka Proteins share price forecast for 2027 has a conservative case of Rs 29.7, a base case of Rs 29.7 and a bull case of Rs 34.2. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.
What is the Mukka Proteins share price today?
Ans. Mukka Proteins trades at Rs 26.49 on NSE as of 9 October 2026, up 0.38% on the day. The 52-week range is Rs 18.27 to Rs 33.29.
Is Mukka Proteins a good stock to buy for 2027?
Ans. The data points in different directions: the PE of 10.76 is at a 69.1% discount to the industry average, EPS grew 12.3% in FY26 and the daily technical setup reads mildly bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.
Can Mukka Proteins stock reach Rs 34.2 in 2027?
Ans. Reaching Rs 34.2 needs EPS to rise 12.3% from Rs 2.47 and the PE multiple to re-rate toward the industry PE of 34.85, plus a daily close above Rs 26.65 (50-day SMA). This is a scenario, not a guarantee.
What are the support and resistance levels for Mukka Proteins?
Ans. The nearest support levels are Rs 25.41 (200-day EMA) and Rs 18.27 (52-week low), and the nearest resistance levels are Rs 26.65 (50-day SMA) and Rs 29.48 (Supertrend).
What are the main risks for Mukka Proteins stock in 2027?
Ans. The main risks to the Mukka Proteins share price forecast are a fall in operating margin from the 7.04% to 11.04% range seen since FY22, slower revenue growth after FY26 revenue was up 44.7%, and thin trading volumes. Debt to equity of 1.56 adds balance sheet sensitivity.
How is the Mukka Proteins target price for 2027 calculated?
Ans. Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 12.1% growth, the base case 12.2% and the bull case 12.3%, all drawn from the company’s reported FY26 and 4-year EPS growth.
